SCHEMBL715944

SCHEMBL715944

CN(C)c1ccc(C(N)S(=O)(=O)c2ccc(Cl)cc2Cl)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.46
MAPT P10636 4/20 0.46
HTT P42858 2/20 0.46
KDM4E B2RXH2 2/20 0.43
HPGD P15428 1/20 0.43
ALOX15 P16050 1/20 0.43
HSD17B10 Q99714 1/20 0.43
FLT1 P17948 2/20 0.42
FLT4 P35916 2/20 0.42
KDR P35968 2/20 0.42
HSD11B1 P28845 1/20 0.39
TRPV4 Q9HBA0 2/20 0.38
TDP1 Q9NUW8 4/20 0.38
LMNA P02545 2/20 0.37
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
GFER P55789 1/20 0.35
TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4879959 0.75 KDM4E (0.59) ALDH1A1MAPTHTTKDM4EHPGD
SCHEMBL4880800 0.71 MAPT (0.79) ALDH1A1MAPTHTTFLT1FLT4
SCHEMBL714553 0.71 ACLY (0.38) ALDH1A1MAPTKDM4ETDP1MEN1
SCHEMBL13797489 0.70 TRPV4 (0.48) ALDH1A1MAPTHTTHPGDHSD11B1
SCHEMBL715945 0.69 MAPT (0.51) ALDH1A1MAPTHTTHSD17B10FLT1
SCHEMBL23251426 0.68 TRPV4 (0.47) ALDH1A1MAPTHTTHSD11B1TRPV4
SCHEMBL6558665 0.68 KMT2A (0.50) ALDH1A1MAPTHTTKDM4EHPGD
SCHEMBL11225782 0.67 ALDH1A1 (0.64) ALDH1A1MAPTHTTKDM4EHPGD
SCHEMBL4175248 0.67 KDM4E (0.56) ALDH1A1MAPTHTTKDM4EHSD11B1
SCHEMBL9732423 0.67 TRPV4 (0.46) MAPTHPGDHSD11B1TRPV4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120052057-A9 METHOD FOR SELECTING RESPONDERS TO BLOCKADE OF INTEGRIN RECEPTORS BIOTIE THERAPIES CORPORATION (FI) 2012-03-01 US claimed
US-20110150859-A1 METHOD FOR SELECTING RESPONDERS TO BLOCKADE OF INTEGRIN RECEPTORS BIOTIE THERAPIES CORPORATION (FI) 2011-06-23 US claimed
EP-2140029-A2 A METHOD FOR SELECTING RESPONDERS TO BLOCKADE OF INTEGRIN RECEPTORS Biotie Therapies Corp. (FI) 2010-01-06 EP claimed
WO-2008125738-A2 A METHOD FOR SELECTING RESPONDERS TO BLOCKADE OF INTEGRIN RECEPTORS BIOTIE THERAPIES CORPORATION (FI) 2008-10-23 WO claimed
US-20120052057-A9 METHOD FOR SELECTING RESPONDERS TO BLOCKADE OF INTEGRIN RECEPTORS BIOTIE THERAPIES CORPORATION (FI) 2012-03-01 US disclosed
US-20110150859-A1 METHOD FOR SELECTING RESPONDERS TO BLOCKADE OF INTEGRIN RECEPTORS BIOTIE THERAPIES CORPORATION (FI) 2011-06-23 US disclosed
EP-2140029-A2 A METHOD FOR SELECTING RESPONDERS TO BLOCKADE OF INTEGRIN RECEPTORS Biotie Therapies Corp. (FI) 2010-01-06 EP disclosed
WO-2008125738-A2 A METHOD FOR SELECTING RESPONDERS TO BLOCKADE OF INTEGRIN RECEPTORS BIOTIE THERAPIES CORPORATION (FI) 2008-10-23 WO disclosed